12-6535530-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002046.7(GAPDH):​c.29+669T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 842,918 control chromosomes in the GnomAD database, including 16,801 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3039 hom., cov: 33)
Exomes 𝑓: 0.20 ( 13762 hom. )

Consequence

GAPDH
NM_002046.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0270

Publications

8 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.354 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAPDHNM_002046.7 linkc.29+669T>G intron_variant Intron 2 of 8 ENST00000229239.10 NP_002037.2 P04406-1V9HVZ4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAPDHENST00000229239.10 linkc.29+669T>G intron_variant Intron 2 of 8 1 NM_002046.7 ENSP00000229239.5 P04406-1

Frequencies

GnomAD3 genomes
AF:
0.194
AC:
29563
AN:
152020
Hom.:
3035
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.177
Gnomad AMI
AF:
0.204
Gnomad AMR
AF:
0.212
Gnomad ASJ
AF:
0.106
Gnomad EAS
AF:
0.366
Gnomad SAS
AF:
0.126
Gnomad FIN
AF:
0.209
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.196
Gnomad OTH
AF:
0.176
GnomAD4 exome
AF:
0.197
AC:
136399
AN:
690780
Hom.:
13762
AF XY:
0.197
AC XY:
63168
AN XY:
321422
show subpopulations
African (AFR)
AF:
0.167
AC:
2167
AN:
12972
American (AMR)
AF:
0.210
AC:
176
AN:
838
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
464
AN:
4252
East Asian (EAS)
AF:
0.382
AC:
1124
AN:
2940
South Asian (SAS)
AF:
0.123
AC:
1705
AN:
13812
European-Finnish (FIN)
AF:
0.155
AC:
41
AN:
264
Middle Eastern (MID)
AF:
0.0935
AC:
127
AN:
1358
European-Non Finnish (NFE)
AF:
0.200
AC:
126162
AN:
631800
Other (OTH)
AF:
0.197
AC:
4433
AN:
22544
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5013
10027
15040
20054
25067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6000
12000
18000
24000
30000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.194
AC:
29576
AN:
152138
Hom.:
3039
Cov.:
33
AF XY:
0.194
AC XY:
14405
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.177
AC:
7337
AN:
41488
American (AMR)
AF:
0.212
AC:
3238
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
369
AN:
3466
East Asian (EAS)
AF:
0.367
AC:
1896
AN:
5162
South Asian (SAS)
AF:
0.125
AC:
605
AN:
4830
European-Finnish (FIN)
AF:
0.209
AC:
2215
AN:
10598
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.196
AC:
13335
AN:
67976
Other (OTH)
AF:
0.173
AC:
366
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1237
2475
3712
4950
6187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.192
Hom.:
598
Bravo
AF:
0.196
Asia WGS
AF:
0.240
AC:
833
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
12
DANN
Benign
0.72
PhyloP100
-0.027
PromoterAI
-0.0084
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060621; hg19: chr12-6644696; API